Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
|
|
67.
|
|
|
68.
|
|
|
69.
|
|
|
70.
|
|
|
71.
|
|
|
72.
|
|
|
73.
|
|
|
74.
|
|
|
75.
|
|
|
76.
|
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. [electronic resource] by
- Inoue, K
- Slaton, J W
- Perrotte, P
- Davis, D W
- Bruns, C J
- Hicklin, D J
- McConkey, D J
- Sweeney, P
- Radinsky, R
- Dinney, C P
Producer: 20010419
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
77.
|
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. [electronic resource] by
- Bruns, C J
- Harbison, M T
- Davis, D W
- Portera, C A
- Tsan, R
- McConkey, D J
- Evans, D B
- Abbruzzese, J L
- Hicklin, D J
- Radinsky, R
Producer: 20000829
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
78.
|
Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. [electronic resource] by
- Jonasch, E
- McCutcheon, I E
- Waguespack, S G
- Wen, S
- Davis, D W
- Smith, L A
- Tannir, N M
- Gombos, D S
- Fuller, G N
- Matin, S F
Producer: 20120316
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
79.
|
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. [electronic resource] by
- Shaheen, R M
- Tseng, W W
- Davis, D W
- Liu, W
- Reinmuth, N
- Vellagas, R
- Wieczorek, A A
- Ogura, Y
- McConkey, D J
- Drazan, K E
- Bucana, C D
- McMahon, G
- Ellis, L M
Producer: 20010329
In:
Cancer research vol. 61
Availability: No items available.
|
|
80.
|
Phase II trial of imatinib mesylate in patients with metastatic melanoma. [electronic resource] by
- Kim, K B
- Eton, O
- Davis, D W
- Frazier, M L
- McConkey, D J
- Diwan, A H
- Papadopoulos, N E
- Bedikian, A Y
- Camacho, L H
- Ross, M I
- Cormier, J N
- Gershenwald, J E
- Lee, J E
- Mansfield, P F
- Billings, L A
- Ng, C S
- Charnsangavej, C
- Bar-Eli, M
- Johnson, M M
- Murgo, A J
- Prieto, V G
Producer: 20080917
In:
British journal of cancer vol. 99
Availability: No items available.
|